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Acute salivary gland hypofunction in the duct ligation
model in the absence of inﬂammation
PN Correia, GH Carpenter, SM Osailan, KL Paterson, GB Proctor
Salivary Research Unit, King’s College London Dental Institute at Guy’s, King’s College and St Thomas’ Hospitals, London, UK
OBJECTIVE: The commonly associated aetiology of sali-
vary gland inﬂammation and salivary hypofunction has led
to the widely held belief that inﬂammation causes salivary
gland hypofunction. Indeed, our own recent study
seemed to support this contention. Here, we tested the
hypothesis that, in an acute duct ligation model, elimi-
nating inﬂammation the submandibular gland would
recover normal function.
MATERIALS AND METHODS: Ligation of the rat sub-
mandibular gland excretory duct for 24 h was used to
induce inﬂammation and salivary gland hypofunction. A
group of duct ligated rats was compared with a second
group given dexamethasone, on the day of duct ligation.
Twenty-four hours later salivary gland function was
assessed and salivary glands were collected.
RESULTS: Histology and myeloperoxidase activity assay
revealed a profound decrease in inﬂammatory cell inﬁl-
tration of ligated glands from rats given dexamethasone,
compared with ligated glands in the absence of dexa-
methasone. Salivary ﬂow rate evoked by methacholine
was decreased (P < 0.01) by approximately 56% (ligated
vs control, 79 ± 9 ll min
)1 g
)1 vs 177 ± 11 ll min
)1 g
)1)
and salivary ﬂow from ligated dexamethasone-treated
and ligated glands was similar.
CONCLUSION: Despite eliminating the inﬂammatory
reaction in the ligated gland, salivary hypofunction
was not reversed, suggesting that other mechanisms
must be at work in the ligation-induced salivary hypo-
function.
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Introduction
The majority of salivary gland pathology is inﬂamma-
tory and most salivary gland inﬂammatory diseases
have in common an associated salivary hypofunction
(Van Den Akker and Busemann-Sokole, 1983; Beale
and Madani, 2006; Dawson et al, 2006). Through
sialometry, salivary ﬂow rate can be determined,
conﬁrming salivary gland insult (Mandel and Baur-
mash, 1980). Impaired salivary glands also show
inﬁltrating inﬂammatory cells, suggesting that the onset
of tissue injury requires the activation of inﬁltrating
cells (Humphreys-Beher and Peck, 1999; Fox and
Stern, 2002; Kimura-Shimmyo et al, 2002). Current
evidence suggests that inhibition of salivary secretion
may precede and continue along with tissue destruction
(Humphreys-Beher and Peck, 1999; Fox and Stern,
2002). A transient inﬂammation of salivary glands,
due to ductal ligation, was reported to trigger an
autoimmune disease in some mouse stains. Recently,
we have demonstrated that salivary hyposecretion,
associated with 24 h duct obstruction, was reversed
following 3 days of deligation and that isolated acinar
cell preparations, from ligated glands, showed a
normal elevation of intracellular calcium in response
to cholinergic stimulation. These ﬁndings suggest that
salivary hypofunction is reversed when the cells are
separated from the surrounding inﬂammatory inﬁltrate
(Carpenter et al, 2007). Nonetheless, the contribution
of inﬁltrating cells to salivary gland hypofunction is
still not fully elucidated.
Ligation of the rat submandibular gland excretory
duct has contributed to the understanding of the
pathology of duct obstruction (Cummins et al, 1994),
which ultimately leads to progressive atrophy of the
aﬀected gland (Harrison et al, 1997). The aetiology of
duct obstruction is multiple, but by far the most frequent
cause is salivary calculi formation. Sialolithiasis is the
commonest cause of salivary gland disease presented to
the general dental practitioner, most often aﬀecting the
submandibular gland (Lustmann et al, 1990), and also
seen in the parotid as chronic obstructive parotitis
(Wang et al, 1992; Qi et al, 2005). Although less
frequent, the main glandular duct can become com-
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carcinoma) (Giger et al, 2005) or become obliterated
because of salivary duct strictures (Drage et al, 2002).
Following long-term duct ligation, there is disorga-
nization of the gland parenchyma, dilation of ducts
and progressive atrophy. Inﬁltrates of neutrophils
occur in the early stage of obstruction (1–18 h)
followed by a monocyte invasion evident by 24 h
(Standish and Shafer, 1957; Tamarin, 1979; Norberg
et al, 1988). At this early stage there is a decrease of
saliva secretion in response to all types of secreta-
gogues (Carpenter et al, 2007). There are several
signalling pathways involved in the control of secretion
that can be aﬀected by proinﬂammatory cytokines (IL-
b1, IL-6 TNF-a) and prostaglandins (Yu, 1986; Tanda
et al, 1998; Yamakawa et al, 2000). Nitric oxide can
have a dual eﬀect in salivary gland secretion: it can
mediate cytokine-induced salivary dysfunction, and it
can also participate in the physiological neural regula-
tion (Rettori et al, 2000; Rosignoli et al, 2001). From
48 h of duct ligation onwards, glandular atrophy
becomes obvious with secretory cell degranulation
(Osailan et al, 2006b), which develops to a progressive
decrease in secretory function and gland weight
(Martinez et al, 1982).
Dexamethasone has been used in diﬀerent studies,
whenever it is desirable to limit inﬂammation and
prevent tissue destruction (Jick et al, 1965; Masferrer
et al, 1990; Adesanya et al, 1996; Yang et al, 1998;
Perretti et al, 2002). This glucocorticoid inhibits the
generation of eicosanoids and superoxide anion and is
also a potent suppressor of iNOS expression (Robbins
et al, 1994). In the present study, the duct ligation model
was used to induce acute inﬂammation of the sub-
mandibular gland and dexamethasone was used as an
anti-inﬂammatory to further test the hypothesis that
early salivary hypofunction associated with duct ligation
is caused by inﬂammation.
Materials and methods
Rat submandibular duct ligation – surgical procedure
Young adult male Wistar strain rats (Harlan Labs Ltd,
Loughborough, UK), 192–281 g, were housed under
standard conditions (12 h light⁄dark cycle at 22–25 C)
with a chow pellet diet and water ad libitum. Animal
work was performed according to Home Oﬃce regula-
tions (guidance on the operation on animals was from
the Scientiﬁc Procedures Act 1986). The animals were
weighed and given Ketamine (75 mg kg
)1) and Xylazine
(15 mg kg
)1) i.p., as an equal mixture of each drug.
After the rats were anaesthetized, an intra-oral ap-
proach was taken to dissect the main excretory duct of
the right submandibular gland, through a small incision
in the ﬂoor of the mouth, to avoid the chorda-lingual
nerve (Osailan et al, 2006b). The duct was ligated 5 mm
posterior to the ductal oriﬁce with a metal micro clip
(SLS -CLIP, Vitalitec, Domalain, France) and the
incision was closed with 8⁄0 Ethilon suture (ETHICON
Inc., Johnson & Johnson Health Care Systems, Piscat-
away, NJ, USA). In seven out of 14 rats, dexamethasone
i.m. (5.5 mg kg
)1) was administered before recovery
from anaesthesia. Aseptic conditions were used through-
out the surgical procedure of duct ligation to reduce the
risk of infection. In all animals, the contralateral,
unligated left submandibular gland was used as a
control.
Saliva collection
Gland stimulation was performed 24 h after the duct
ligation. Rats were weighed and anaesthetized with
pentobarbitone (50 mg kg
)1) i.p. and secured in the
supine position on a heated table. A cannula was intro-
duced into the femoral vein. Chloralose (80 mg kg
)1)
was delivered i.v. via the femoral vein to maintain
long-term anaesthesia and additional pentobarbitone
was given, if necessary. The trachea was cannulated so
that clear airways would be provided during cannula-
tion (as methacholine induces secretion in all body
ﬂuids, including mucus secretion in the lungs, which can
cause respiratory distress). Body temperature was
recorded by rectal thermometer and maintained at
38 C. Saline was given i.p. to maintain ﬂuid levels, if
required.
For collection of submandibular saliva, the ducts of
the submandibular glands were exposed, from extra-oral
approach, and cannulated proximal to the gland, with
polyethylene cannulae (Osailan et al, 2006b). The right
submandibular cannula was inserted posterior to the
ligation. Salivation was stimulated with i.v. drugs, as
described below, and saliva samples were collected into
preweighed tubes, weighed, kept on ice and subse-
quently stored at )70 C.
A methacholine stock solution of 14.4 mg ml
)1
(0.07 M) was diluted in saline to 144 lgm l
)1
(0.74 mM). It was delivered i.v. with a syringe pump
rate adjusted to 80 llk g
)1 body weight, such that
methacholine was delivered at 12 lg min
)1 kg
)1. This
drug is a cholinergic agonist and induces saliva ﬂow on
binding to muscarinic receptors (Osailan et al, 2006b).
Saliva was collected from both ducts for 2 min. These
saliva samples contained accumulated levels of salivary
protein, following anaesthesia, and were collected to
check that the system was working, i.e. that saliva was
stimulated and the cannulae were not leaking (Proctor
et al, 2003a). To distinguish between diﬀerent stimula-
tions, a saline bolus injection was delivered i.v. between
each stimulation. All subsequent saliva samples were
collected for 5 min and amounts determined gravimet-
rically (Anderson et al, 1995). Isoprenaline, a b-adren-
ergic receptor agonist, strongly stimulates protein
secretion from submandibular acinar cells (Proctor
et al, 2003b). Isoprenaline 1 mg ml
)1 (4 mM) stock
was diluted to 5 lgm l
)1 (0.02 mM) and administered
at a rate of 0.4 lg min
)1 kg
)1. As such stimulation
produces a slow ﬂow of saliva, to allow a proper
measurement of protein secretion, a high dose of
methacholine (144 lgm l
)1) was added to isoprenaline.
Immediately after the end of the collection period, each
submandibular gland was removed, separated from the
sublingual gland and weighed. The animals were killed
with an overdose of pentobarbitone.
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After removal, each submandibular gland was divided
into pieces. For biochemical analyses, tissue pieces were
immediately frozen in liquid nitrogen. For morphology–
immunohistochemical studies, tissues were placed in
OCT (embedding medium, Raymond A Lamb Ltd., East
Sussex, England) then frozen in isopentane and cooled in
liquid nitrogen. For conventional histochemistry, tissues
were ﬁxed in formol sucrose (4% formaldehyde, 7.5%
sucrose, 0.08 M cacodylate buﬀer pH 7.2).
Histochemistry
Formol sucrose ﬁxed tissue was processed to paraﬃn
embedding and 5 lm paraﬃn sections were cut,
mounted on slides and stained with Ehrlich haematoxy-
lin and 1% eosin (H&E). Alcian blue⁄periodic acid
Schiﬀ’s stains (AB⁄PAS) were used for the demonstra-
tion of acinar and ductal secretory granules and
p-dimethylaminobenzoaldehyde (DMAB) was used for
granular convoluted ductal cell secretory granules.
Morphometric analysis
An estimate of acinar areas was performed using Leica
TCS SP2 software, version 2.1 (Leica Microsystems
Heidelberg GmbH, Germany). From ligated, dexameth-
asone-treated ligated glands and respective contralateral
control glands, 20 acini per gland were randomly
selected and the mean area (lm
2) calculated.
Total salivary protein assay
Total salivary protein was assayed spectrophotometri-
cally (Abs 215 nm). Samples were diluted 1⁄100 with
double distilled water and absorbance measured at
215 nm using a spectrophotometer (Ultrospec 4050,
Biochrom, Cambridge, UK). Double distilled water was
used as a blank and bovine serum albumin (BSA; Sigma,
Poole, UK) was used to construct a standard curve.
Total glandular protein assay
The Bicinchoninic Acid (BCA) protein assay kit (Pierce
Biotechnology, Rockford, IL, USA) was used in a
microplate. Submandibular gland homogenates were
diluted (1⁄50) with water and then loaded 25 ll in the
wells. Subsequently, the BCA working reagent was
added and the plates were incubated for 45 min at 37 C
and afterwards allowed to cool down to room temper-
ature. The sample reaction was read at 540 nm. A
standard curve was created using BSA, to determine the
protein concentration of each sample.
Glandular peroxidase assay
Peroxidase was assayed enzymatically using the sub-
strate 2,7-dichloroﬂuorescein diacetate (LDADCF;
Molecular Probes Inc., Eugene, OR, USA) as described
by Proctor and Chan (1994). LDADCF was activated to
dichloroﬂuorescein (LDCF) with 1 M sodium hydrox-
ide and then neutralized with 67 mM phosphate buﬀer
(pH 6.0). Glandular homogenates, 4% (w ⁄ v) in phos-
phate containing buﬀer (pH 6), were centrifuged at
10 000 g for 10 min. The supernatant was removed and
diluted 1⁄200 in phosphate buﬀer for assay. The samples
were loaded on to a 96-well plate (Iwaki Co., Tokyo,
Japan) and placed in a bath at 37 C. Hydrogen
peroxide, phosphate buﬀer containing potassium thio-
cyanate and LDCF were added sequentially. The
substrate reaction was stopped after 4 min by 1 M
sodium hydroxide. Fluorescence of the product dichlo-
roﬂuorescein (DCF) was read in a ﬂuorimeter (Per-
kinElmer Life and Analytical Sciences, Milan, Italy) set
at 485 nm excitation and 538 nm emission. DCF (Sigma
Chemicals Ltd, Perth, Western Australia) was used as a
standard by diluting 10 mM DCF stock to a 2 lM
solution (Proctor and Chan, 1994).
Myeloperoxidase assay
Following centrifugation, the tissue pellets from glan-
dular homogenates prepared as above, were resus-
pended in phosphate buﬀer containing 13.7 mM
hexadecyltrimethylammonium bromide (Sigma Chemi-
cals Ltd.) and 10 mM EDTA. The samples were diluted
and loaded on to a 96-well plate and placed in a bath at
37 C. Hydrogen peroxide, phosphate buﬀer and tetra-
methyl benzidine (TMB) were added sequentially. The
substrate reaction was stopped after 4 min by sulphuric
acid. The absorbance of the sample reaction was read at
460 nm. Diﬀerent dilutions of human myeloperoxidase
enzyme of known concentration were used to obtain the
standard curve (Sigma Chemicals Ltd.). Myeloperoxi-
dase activity was expressed as mU per gram tissue.
Dapsone (diaminodiphenylsulfone, Sigma Chemicals
Ltd.), a selective inhibitor of peroxidases, other than
myeloperoxidase, was used to conﬁrm the speciﬁcity of
the assay (Thomas et al, 1994).
Direct potentiometry
The concentration of chloride ions in the saliva samples
was assayed using an ion-selective electrode (ISE) in
combination with a potassium nitrate reference elec-
trode (ELIT Ion Analyser, Nico 2000 Ltd, Harrow,
UK), eight channel ion analyser and computer interface
software. Before use, the ISE was allowed to stand in a
chloride solution of 1000 mg l
)1 for 5 min or until the
milliVolt (mV) output reached a stable reading. The ISE
was calibrated by measuring two standard chloride
solutions of 1 and 10 mg l
)1, within the concentration
range expected for the samples, and a straight line of mV
vs concentration plotted to provide the calibration data.
Between each measurement⁄sample, electrodes were
washed with de-ionized water and dried to avoid cross
contamination. The diluted saliva samples (1⁄100) were
measured in the same way as the standards and the
results displayed as mg l
)1. To obtain a high precision,
every 10 samples, recalibration was performed.
Statistical analysis
Data were analysed using one-way ANOVA and paired
Student’s t test when comparing contralateral glands
from the same group and unpaired Student’s t test
for comparisons between glands in dexamethasone-
treated and untreated series. Results are expressed
as means ± s.e.m. and P < 0.05 was considered
signiﬁcant.
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Submandibular tissue
After 24 h of duct ligation there was a signiﬁcant
increase (P < 0.01, n = 7) in the submandibular gland
weight comparing with the contralateral gland. The
mean weight of ligated submandibular gland in dexa-
methasone-treatedratswasdecreasedby20%(P < 0.02,
n = 7) compared with the contralateral control sub-
mandibular gland (Figure 1a). There was no diﬀerence
in the rat body weight between the dexamethasone
treated and untreated groups (data not shown).
As seen in Figure 2c, the H&E stained ligated gland
shows a moderate inﬂammatory inﬁltrate and an
increased extracellular space. The inﬁltrate was com-
posed of neutrophils and macrophages and mainly
dispersed in the intralobular and interlobular connective
tissue. In the dexamethasone-treated ligated subman-
dibular gland there was no inﬁltrating inﬂammatory
cells and a marked reduction in the interstitial oedema
compared with ligated submandibular gland without
dexamethasone (Figure 2b,c). Acinar cells looked
shrunken and the gland showed a more compact
appearance in the dexamethasone-treated ligated gland
(Figure 2b) when compared with the contralateral
control gland (Figure 2a). Comparison of control
glands showed that dexamethasone treatment per se
did not cause obvious changes in glandular morphology
(ﬁgure not shown).
Staining of acinar and ductal secretory material with
AB ⁄ PAS showed that ligated and dexamethasone-
treated ligated submandibular glands (Figure 2f,e),
contained fewer secretory granules which were more
localized in the apical pole, compared with respective
control submandibular gland (Figure 2d). The DMAB
staining, speciﬁc for stored tissue kallikreins of the
granular convoluted ducts (Shori et al, 1997) did not
show a substantial diﬀerence between ligated vs control
glands and dexamethasone-treated ligated vs contralat-
eral control glands (data not shown).
Quantitative morphological analysis indicated that
the area of acini from ligated glands was signiﬁcantly
reduced, in both ligated (n =6 ,P < 0.001) and dexa-
methasone-treated ligated animals (n =5 ,P < 0.001),
compared with their respective control glands (Fig-
ure 1b). Mean acini area from control dexamethasone-
treated glands was higher than control glands,
(P < 0.001, unpaired Student’s t test).
Duct ligation alone led roughly to a 10-fold increase
in the myeloperoxidase activity (n =6 , P < 0.02),
compared with the contralateral control gland (Fig-
ure 3). Dexamethasone-treatment dramatically reduced
the myeloperoxidase activity in the ligated gland (n =5 ,
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Figure 1 Effects of 24-h duct ligation with and without the presence of dexamethasone on submandibular gland weight and acinar cell size, stored
acinar cell peroxidase and glandular protein content. Results were compared using paired and unpaired Student’s t test and P < 0.05 considered
signiﬁcant. (a) Mean submandibular gland weight of 24-h ligated gland is increased comparing with control glands (n = 7). In contrast,
dexamethasone-treated ligated glands are smaller than respective contralateral control (n = 7) and control and ligated untreated submandibular
glands. (b) The mean area of acini from 24-h duct ligated glands and dexamethasone-treated ligated glands shows a reduction in the size of acini in
the ligated glands (n = 100), and dexamethasone-treated ligated glands (n = 100), when compared with contralateral controls, (n = 100). Acinar
size of control dexamethasone-treated glands was bigger than acini of control glands (unpaired Student’s t test). (c) Secretory peroxidase activity
from submandibular gland homogenates. In the dexamethasone-treated ligated group, after 24 h, the activity of peroxidase was signiﬁcantly
decreased, n = 5. In the 24-h duct ligation group, the diﬀerence was not signiﬁcant, n =6 .( d) Total protein from submandibular gland
homogenates. In the dexamethasone-treated ligated glands (n = 7), total protein content decreased compared with control dexamethasone-treated
and untreated glands
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levels (Figure 3). Myeloperoxidase was signiﬁcantly
lower in control dexamethasone-treated glands
compared with control glands (P < 0.01, unpaired
Student’s t test).
Glandular content of secretory peroxidase activity was
reduced by 29% after 1 day of duct blockage
(743 ± 132 nmol DCF g
)1vs530 ± 97 nmolDCF g
)1,
n = 6) and by 50% (878 ± 86 nmol DCF g
)1 vs
438 ± 52 nmol DCF g
)1, n =5 , P < 0.02) in the
dexamethasone-treated ligated group (Figure 1c).
Total glandular content of protein was reduced by
27% in dexamethasone-treated ligated glands (635 ±
123 lgg
)1 vs 876 ± 107 lgg
)1, n = 7) compared with
contralateral control glands, which shows a similar trend
to secretory peroxidase. In ligated glands there was a
3% reduction in glandular total protein content
(827 ± 79 lgg
)1 vs 849 ± 52 lgg
)1 n = 6), which
was not statistically signiﬁcant.
Submandibular secretion
The methacholine (12 lg min
)1 kg
)1) evoked ﬂow rate
from dexamethasone-treated ligated submandibular
glands was decreased (n =5 , P < 0.01) by 56%
(79 ± 9 ll min
)1 g
)1) compared with contralateral con-
trol glands (177 ± 11 ll min
)1 g
)1) and by 55%
(P < 0.05) compared with control untreated glands.
In the absence of dexamethasone, the ﬂow rate from
ligated glands decreased (n =7 ,P < 0.001) by 78%
compared with contralateral glands, (Figure 4a). There
was no statistically signiﬁcant diﬀerence between
salivary ﬂow rate in ligated glands compared with
dexamethasone-treated ligated glands.
Salivary protein output evoked by combined isopren-
aline and methacholine was reduced by 58% (n =5 ,
P < 0.01) from dexamethasone-treated ligated glands
(671 ± 133 vs 1583 ± 185 lg min
)1 g
)1) and reduced
by 63% (n =4 , P < 0.01) from the ligated glands
(518 ± 84 vs 1394 ± 151 lg min
)1 g
)1) compared with
respective contralateral control glands, as seen in
Figure 4b. Dexamethasone-treated ligated glands had
a lower protein output compared with control untreated
glands (P < 0.01).
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Figure 2 Morphology of stimulated submandibular gland. In the top row, H&E staining for general morphology and in the lower row, AB ⁄ PAS
reagentstainingshowingsalivaryglycoproteincontainingsecretorygranules.(a)and(d)Dexamethasone-treatedcontrolsubmandibulargland.(b)and
(e)Dexamethasone-treatedligatedsubmandibulargland.(c)and(f)Ligatedsubmandibulargland.(a)and(d)Illustrateanormalsubmandibulargland
histologicalarchitecturewithabundantcloselypackedacini(a) andlargespaced,diﬀerentsizedducts(d). (b) Containsacondensedstromawithsome
atrophicacini(arrowheads)andshowsamarkedreductionin inﬂammatorycellscomparedwith(c); arrowson(c) indicateinﬂammatory cells.(e) and
(f) Contain fewer acinar cell secretory granules than (d). All micrographs are ·125 magniﬁcation. Scale bars = 20 lm
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Figure 3 Effect of 24-h duct ligation with and without the presence of
dexamethasone on myeloperoxidase activity. Myeloperoxidase activity
after 24-h duct ligation is greatly increased, compared with control,
n = 6. Dexamethasone dramatically reduced myeloperoxidase activity
in duct ligated glands, n = 5. Myeloperoxidase was decreased in the
control dexamethasone-treated group compared with the control
group (unpaired Student’s t test)
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glands (2546 ± 123 vs 882 ± 170 mg l
)1, n =5 ,
P < 0.001) and dexamethasone-treated ligated glands
(P < 0.01) was signiﬁcantly greater than that from
control glands. While chloride concentration in saliva
from the dexamethasone-treated ligated glands
(2202 ± 336 vs 1593 ± 310 mg l
)1, n = 6), was not
signiﬁcantly increased (Figure 4c) compared with
contralateral control glands.
Discussion
Dexamethasone treatment reversed salivary gland
inﬂammation and yet the most important markers of
salivary gland function, ﬂow rate, protein secretion and
chloride concentration indicated that hypofunction
persisted. Total salivary protein output, in response to
isoprenaline-methacholine stimulation, reveals mainly
acinar cell protein secretory function. In our experi-
ments, the reduction in this parameter indicates impair-
ment of the normal secretory process, which has
previously been reported as a consequence of duct
blockage (Osailan et al, 2006a; Carpenter et al, 2007).
Salivary chloride concentration was analysed as a
marker of ductal cell absorptive function. In the
dexamethasone-treated ligated glands, chloride concen-
tration was still increased by 150%, compared with the
control untreated glands, indicating impaired duct
reabsorption. The low salivary ﬂow from these glands
would normally result in low salivary levels of chloride,
as chloride concentration is correlated with salivary ﬂow
rate (Thaysen et al, 1954; Martinez et al, 1982).
Earlier, we reported the presence of inﬁltrating
inﬂammatory cells and salivary gland hypofunction,
following acute experimental duct ligation, (Carpenter
et al, 2007). The reduction in salivary secretion in the
absence of widespread damage, suggested an inﬂuence of
inﬂammatory cells on parenchymal function. The release
of cytokines by inﬂammatory and glandular cells has
been suggested to decrease the release of neurotransmit-
ters and the response of the parenchymal cells to
neurotransmitters (Fox and Stern, 2002). It has also
been shown that exogenous prostaglandins (PGE1,
PGE2 and PG2a) markedly reduced cholinergic-evoked
submandibular gland ﬂow of saliva (Yu, 1986). Exper-
iments using a systemic lipopolysaccharide infusion
induced inhibition of salivation, which appeared to be
mediated by increased PGE production, via nitric oxide
release and cyclooxygenase activation (Lomniczi et al,
2001). In Sjo ¨ gren’s syndrome there are increased levels of
inﬂammatory mediators (PGE2, thromboxane B2, IL-2
and IL-6) in saliva, which can assist in the diagnosis
(Tishler et al, 1996, 1997; Streckfus et al, 2001; Kaufman
and Lamster, 2002). These studies suggest a role of
inﬂammatory mediators in salivary gland hypofunction.
The aim of the present work was to evaluate if the
glucocorticoid dexamethasone could preserve salivary
function, following duct obstruction. Dexamethasone is
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Figure 4 Effects of 24-h duct ligation alone and in the presence of dexamethasone on submandibular gland function. (a) The mean ﬂow rate of
methacholine-evoked saliva (in units of microlitres per minute per gram gland wet weight) from the 24-h ligated glands was reduced by 78%
compared with control glands (n = 7). In the dexamethasone-treated ligated glands, ﬂow rate was reduced by 56% compared with contralateral
control submandibular glands (n = 5) and by 55% compared with control untreated submandibular glands. Following duct ligation, salivary
gland ducts were cannulated posterior to the site of clip ligation. (b) Salivary protein output induced by isoprenaline with methacholine is
signiﬁcantly reduced in both 24-h duct ligated (n = 4) and dexamethasone-treated ligated glands (n = 5). (c) Mean chloride concentration of
methacholine-evoked saliva was increased in the 24-h ligated (n = 5) and dexamethasone-treated ligated glands (n = 6), when compared with the
control untreated glands
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Oral Diseasesan extremely potent and often used anti-inﬂammatory
drug, known to eﬃciently inhibit polymorphonuclear
cell function and tissue invasion, key factors in the host’s
acute inﬂammatory response (Perretti et al, 2002). In a
previous study, it was observed that several administra-
tions of dexamethasone improved salivary secretion
after 3 days of a retrograde infusion of adenovirus in the
submandibular gland (Adesanya et al, 1996). In the duct
ligation model of inﬂammation, together with the
inﬂammatory cell inﬁltrate, there is also ﬂuid exudate
leading to an increased extracellular ﬂuid. It could be
hypothesized that this exudate contributed to salivary
hypofunction, as it leads to the loss of the normal
compact glandular structure. This aspect of the inﬂam-
matory reaction was also overcome, as dexamethasone
eﬃciently reduced oedema in the inﬂamed tissues. To
determine the eﬀectiveness of dexamethasone, besides a
histological examination of the number of neutrophils in
H&E stained slides, myeloperoxidase activity was
assayed as an indicator of tissue neutrophil accumula-
tion (Krawisz et al, 1984; Thomas et al, 1994; Barocelli
et al, 2006; Xinmin et al, 2006). Myeloperoxidase activ-
ity was increased after 24 h of duct ligation, correlating
to the histological ﬁndings, and dramatically reduced
after treatment with dexamethasone.
Salivary gland weight was reduced in dexamethasone-
treated ligated submandibular glands compared with the
contralateral side. Gland histology suggests that paren-
chymal degranulation together with decreased acinar
volume and lack of inﬂammatory oedema, probably
explain the diﬀerence in the gland weight. Noticeably,
most of the acini appeared to be smaller in the ligated
glands compared with control glands. To obtain a direct
estimation of the acinar size, further morphometric
analyses were undertaken. The mean area showed a
reductioninthesizeofaciniintheligatedglands,notonly
in the dexamethasone-treated, but also in the non-treated
group. From earlier studies, it was considered that 24 h
after ligation, the degree of atrophy was not marked
(Tamarin, 1971; Shiba et al, 1972). Our results suggest
that the mechanism of acinar atrophy is switched on very
early, regardless of the presence of an inﬂammatory
inﬁltrate. Unlike long-term duct ligation in which glan-
dular shrinkage is due to cell death (Walker and Gobe,
1987;Scottet al,1999),noevidentsignsofapoptosiswere
found at 24 h, which agrees with earlier studies (Takah-
ashi et al, 2000; Carpenter et al, 2007). Consistent with
acinaratrophy,tissuelevelsofperoxidase,astoredacinar
cell secretory protein, were reduced in the dexametha-
sone-treated duct ligated glands. In the untreated group,
glandular peroxidase concentration was decreased, but
not signiﬁcantly reduced, as found previously (Osailan
et al, 2006b). In the dexamethasone-treated group,
the signiﬁcant reduction in peroxidase levels (50% in
the dexamethasone-treated ligated gland vs 21% in the
ligated gland) appears to be consistent with a greater
reduction in the acinar size (40% in the dexamethasone-
treated ligated gland vs 21% in the ligated gland). Total
proteinfromglandularhomogenatesincludesallproteins
from diﬀerent cell populations in the submandibular
gland. The reduction of glandular proteins in the dexa-
methasone-treated ligated gland would support the
evidence of an atrophic hypofunctioning gland. In the
ligated glands, protein content is similar to control
glands. The presence of inﬂammatory cells in the ligated
glands may increase protein concentration and oﬀset any
reduction because of acinar size and content of proteins.
This result suggests that acute hypofunction of the
submandibular gland, in the absence of an inﬂammatory
response, is linked with early atrophy as measured by
organ and acinar size, total glandular proteins, stored
acinar peroxidase and abrupt reduction in salivary
secretion. Histologically, AB⁄PAS staining showed
degranulation of parenchymal cells and enlarged ductal
lumina, in both dexamethasone-treated and untreated
ligated glands, compared with respective control glands.
Apparent early atrophy will further be investigated in the
future, as acinar atrophy is generally associated with
chronic active inﬂammation.
It was initially hypothesized that dexamethasone
could reverse salivary hypofunction. Some studies have
justiﬁed its beneﬁcial role in salivary (Adesanya et al,
1996) and lung epithelial cells, as dexamethasone is
known to inhibit inducible nitric oxide synthase and
cyclooxygenase-2 (Robbins et al, 1994). The present
data indicate that the inﬂammatory process after 24 h of
duct blockage is not the main mechanism accounting for
the reduction in salivary acinar secretion. This fact
suggests that a non-inﬂammatory mechanism, possibly
early acinar atrophy, leads to salivary gland hypofunc-
tion. Additional studies of the gene and protein expres-
sion patterns in the ligated submandibular gland may be
relevant to determine speciﬁc mediators that induce
atrophy and salivary hyposecretion. Transforming
growth factors-a and b1, platelet-derived growth factor
and reactive oxygen intermediates seem to be involved in
glandular atrophy. In particular, endogenous IL-10, a
crucial regulator of ﬁbrogenetic processes that limits the
severity of ﬁbrosis and glandular atrophy will be further
studied (Demols et al, 2002).
Understanding the mechanisms underlying early sal-
ivary hypofunction will help in selecting the best
therapeutic option for clinically evident dry mouth and
symptomatic xerostomia. To the best of our knowledge,
it is the ﬁrst time that inﬂammation is abolished from
acute hypofunctioning submandibular glands using the
duct ligation model. Our data showed that in the
absence of inﬂammation, submandibular gland function
is still impaired. A novel ﬁnding was the appearance of
atrophy only 24 h after the initial insult.
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